Drug Target Review
AUGUST 11, 2023
Since December 2019, SARS-CoV-2 (COVID-19) infection has become a worldwide urgent public health concern. 1 The study reveals a novel bioinformatic approach and tool that holds the potential to empower researchers in designing vaccines capable of inducing a stronger immune response.
Drug Target Review
JULY 12, 2023
Using our bioinformatics expertise, we then map those profiles onto a large database of patient data – the AACR Project GENIE database – to translationally predict which tumour types are likely to be most responsive to monotherapy or combination therapy to our drug candidate.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Broad Institute
JULY 10, 2023
In 2019, they compared the scores’ performance across a wider range of populations, and showed how the scores were about half as likely to reliably predict disease among Hispanic/Latino Americans populations, South Asians, and East Asians as Europeans, and only one-fifth as likely to accurately predict them among African populations.
Drug Target Review
MARCH 28, 2024
Her major focus has been untargeted metabolomics method development and bioinformatics solutions for structure elucidation. Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. References Newman DJ, Cragg GM. Journal of Natural Products. 2020;83(3):770–803. doi:10.1021/acs.jnatprod.9b01285
Elrig
APRIL 29, 2024
With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Driven by an interest in structural biochemistry and drug discovery (DD), I joined AstraZeneca in 2019. Bioinformatics is all about bringing together different areas of knowledge.
The Pharma Data
MARCH 2, 2021
In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros. Gubra experts cover a number of pre-clinical disciplines: in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays. Our significant investment of almost 3.5
The Pharma Data
JANUARY 24, 2021
Pamer joined the University of Chicago from Memorial Sloan Kettering Cancer Center in New York City, where he served as head of the Division of Subspecialty Medicine from 2011 to 2018 and director of the Center for Microbes, Inflammation and Cancer from 2010 to 2019. Diversigen, Inc.
Expert insights. Personalized for you.
98 
Let's personalize your content